XML 38 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2021   145,921,530      
Beginning balance at Dec. 31, 2021 $ 375,343 $ 1,459 $ 1,334,138 $ (956,267) $ (3,987)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in at-the-market offering, net of offering expenses (in shares)   14,711,770      
Issuance of common stock in at-the-market offering, net of offering expenses 66,448 $ 147 66,301    
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (in shares)   925,455      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (1,838) $ 9 (1,847)    
Issuance of common stock under employee stock purchase plan (in shares)   359,468      
Issuance of common stock under employee stock purchase plan 1,115 $ 4 1,111    
Stock-based compensation 23,402   23,402    
Foreign currency translation adjustment (14,040)       (14,040)
Net pension gain 130       130
Net unrealized (loss) gain on marketable securities, net of tax (1,101)       (1,101)
Net loss (140,305)     (140,305)  
Ending balance (in shares) at Sep. 30, 2022   161,918,223      
Ending balance at Sep. 30, 2022 309,154 $ 1,619 1,423,105 (1,096,572) (18,998)
Beginning balance (in shares) at Jun. 30, 2022   153,352,502      
Beginning balance at Jun. 30, 2022 318,281 $ 1,534 1,373,324 (1,043,417) (13,160)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in at-the-market offering, net of offering expenses (in shares)   8,483,104      
Issuance of common stock in at-the-market offering, net of offering expenses 42,174 $ 85 42,089    
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (in shares)   82,617      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (101) $ 0 (101)    
Stock-based compensation 7,793   7,793    
Foreign currency translation adjustment (6,028)       (6,028)
Net pension gain 55       55
Net unrealized (loss) gain on marketable securities, net of tax 135       135
Net loss (53,155)     (53,155)  
Ending balance (in shares) at Sep. 30, 2022   161,918,223      
Ending balance at Sep. 30, 2022 309,154 $ 1,619 1,423,105 (1,096,572) (18,998)
Beginning balance (in shares) at Dec. 31, 2022   166,793,320      
Beginning balance at Dec. 31, 2022 294,958 $ 1,668 1,450,239 (1,148,545) (8,404)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in at-the-market offering, net of offering expenses (in shares)   8,249,261      
Issuance of common stock in at-the-market offering, net of offering expenses 15,106 $ 83 15,023    
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (in shares)   1,481,508      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (1,404) $ 15 (1,419)    
Issuance of common stock under employee stock purchase plan (in shares)   755,586      
Issuance of common stock under employee stock purchase plan 719 $ 7 712    
Stock-based compensation 21,256   21,256    
Foreign currency translation adjustment 981       981
Net pension gain 2       2
Net unrealized (loss) gain on marketable securities, net of tax 840       840
Net loss (197,536)     (197,536)  
Ending balance (in shares) at Sep. 30, 2023   177,279,675      
Ending balance at Sep. 30, 2023 134,922 $ 1,773 1,485,811 (1,346,081) (6,581)
Beginning balance (in shares) at Jun. 30, 2023   177,074,546      
Beginning balance at Jun. 30, 2023 233,642 $ 1,771 1,479,725 (1,241,918) (5,936)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (in shares)   205,129      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (101) $ 2 (103)    
Stock-based compensation 6,189   6,189    
Foreign currency translation adjustment (1,144)       (1,144)
Net pension gain 5       5
Net unrealized (loss) gain on marketable securities, net of tax 494       494
Net loss (104,163)     (104,163)  
Ending balance (in shares) at Sep. 30, 2023   177,279,675      
Ending balance at Sep. 30, 2023 $ 134,922 $ 1,773 $ 1,485,811 $ (1,346,081) $ (6,581)